Screener
Boston Scientific BSX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Boston Scientific’s reported figures.
Based on trailing twelve months.
The source filing: Boston Scientific’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 6:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885725-26-000033
FAQ
- What is Boston Scientific's EBITDA margin?
- Boston Scientific (BSX) reported EBITDA margin of 25.2% in Q1 2026.
- How has Boston Scientific's EBITDA margin changed year-over-year?
- Boston Scientific's EBITDA margin increased by 6.7% year-over-year, from 23.6% to 25.2%.
- What is the long-term trend for Boston Scientific's EBITDA margin?
- Over 4 years (2021 to 2025), Boston Scientific's EBITDA margin has grown at a 6.5% compound annual growth rate (CAGR), from 19.3% to 24.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Boston Scientific's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude